Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum LSL Pharma Group Inc LPGIF


Primary Symbol: V.LSL Alternate Symbol(s):  V.LSL.DB

Healthcare Biotechnology
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specialized in the development, manufacturing and commercialization of sterile ophthalmic pharmaceuticals, as well as natural health products in solid and liquid dosage forms. It specializes in the manufacturing and marketing of natural health products (NHPs). The Company manufactures a range of NHPs in liquid... see more

TSXV:LSL - Post Discussion

LSL Pharma Group Inc > Groupe LSL Pharma Update on Increased Production Capacity
View:
Post by Betteryear2 on Jun 20, 2023 7:33pm

Groupe LSL Pharma Update on Increased Production Capacity

BOUCHERVILLE, Quebec, June 20, 2023 (GLOBE NEWSWIRE) -- GROUPE LSL PHARMA INC (TSXV: LSL) - Groupe LSL Pharma Inc. ("the Company" or " LSL Pharma Group "), a Canadian integrated pharmaceutical company, is pleased to announce that its total annual production capacity will be increased by approximately 35% to 40% as early as 2023, and further for 2024 and 2025, with its new facility in La Pocatire and a series of manufacturing optimizations in Upton. The Company would also like to point out that its Management's Discussion and Analysis and its unaudited consolidated financial statements for the first quarter ended March 31, 2023 were filed on SEDAR on May 30, 2023.

Groupe LSL Pharma Update on Increased Production Capacity (globenewswire.com)
Be the first to comment on this post
LSL Pharma Group Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities